Skip to main content
Back to grants dashboard
OpenUpdated 9 Jun 2026Research Innovation

MRC: research grant: applicant-led

Medical Research Council (MRC) · United Kingdom

Summary

Deadline

Rolling

Complexity

Medium

Time to apply

20-60 hours

Updated

9 Jun 2026

No overview is currently available for this scheme.

Eligibility

Applicant types

Research

Business size

Research organisation

Industries

Sector agnostic

Match funding

Required

Requirements

Researchers employed by eligible UK research organisations who will direct and actively engage in the project. UK research organisation eligible for MRC funding must lead applicant-led research grant. Fundamental discovery research, early translational research, proof-of-concept studies, and research addressing interrelated scientific questions.

Eligible applicants

Researchers employed by eligible UK research organisations who will direct and actively engage in the project.

Funding and scope

Benefit amount

£500,000 to £5 million

Total fund available

Not specified

Funding intensity

MRC typically funds 80% of FEC.

Payment type

Grant (typically 80% FEC in arrears)

Eligible scope

Fundamental discovery research, early translational research, proof-of-concept studies, and research addressing interrelated scientific questions.

Eligible expenses

Not specified

Ineligible costs

  • Costs not eligible under MRC funding opportunity and UKRI FEC terms.

Application and risks

Application platform

UKRI Funding Service

Competitiveness

Competitive Selection

Decision timeline

Not specified

Assessment process

Eligibility check → expert peer review → shortlisting panel → funding panel decision.

Required documents

Not specified

Appendices

Not specified

Assessment criteria

  • Vision of the project, robustness of approach, capability of the research team, ethical considerations, and justification of resources.

Timeline and partners

Opening date

7 Apr 2026

Project duration

18 months to 5 years.

Project start

Not specified

Project end

Not specified

Co-funders

Not specified

Collaboration rules

  • International researchers may participate as project co-lead (international) or as project partners.

Consortium requirements

  • Single lead organisation or permitted collaborations per MRC research grant guidance.

Additional guidance

[{"label":"Grant Name","value":"MRC: Research Grant (Applicant-Led)"},{"label":"Funding Amount","value":"Usually £400,000 to £3.1 million (100% full economic cost). No strict upper limit if justified."},{"label":"Programme Objective","value":"To support applicant-led research that advances understanding of human health and disease, including discovery and early translational research."},{"label":"Research Scope","value":"Projects aimed at accelerating diagnosis, advancing treatment, and preventing human illness."},{"label":"Eligible Research Areas","value":"Infections and immunity; molecular and cellular medicine; neurosciences and mental health; population and systems medicine."},{"label":"Collaboration Model","value":"Research projects may involve multiple research groups or organisations and encourage interdisciplinary and team-science approaches."},{"label":"Activities Not Funded","value":"Later-phase clinical trials, PhD studentships, infrastructure-only requests, publication costs, and bridge funding between grants."},{"label":"Eligible Costs","value":"Salary contributions for project lead and co-leads, research and technical staff, consumables, equipment, travel, dissemination, estates and indirect costs, and NHS research costs where applicable."},{"label":"International Cost Limit","value":"Up to 30% of total project costs for international co-leads from high-income countries, India and China."},{"label":"Application Submission","value":"The lead research organisation submits the application through the UKRI Funding Service."},{"label":"Core Team Roles","value":"Project lead, project co-lead (UK), project co-lead (international), specialist, grant manager, professional enabling staff, research associate, technician, visiting researcher, researcher co-lead."},{"label":"Key Application Sections","value":"Summary, vision, approach, reproducibility and statistical design, data management plan, applicant and team capability, ethics and RRI, resources and cost justification, project partners, international collaboration."},{"label":"Assessment Frequency","value":"Panels expected to run approximately three times per year."},{"label":"Review Timeline","value":"The assessment process typically takes up to 10 months."},{"label":"Project Partners","value":"Partners may provide cash or in-kind contributions such as equipment, facilities, data, materials, or staff time."},{"label":"Industry Collaboration","value":"Must follow the Industry Collaboration Framework (ICF) if industry partners are involved."},{"label":"Data Management Requirement","value":"Applicants must provide a detailed data management and sharing plan aligned with MRC policies."},{"label":"Ethical Compliance","value":"Applicants must address ethical issues, responsible research and innovation considerations, and regulatory approvals if relevant."},{"label":"Additional Compliance","value":"Trusted Research and Innovation principles and export control considerations may apply."},{"label":"Application Limit","value":"Maximum of two applications as project lead across MRC applicant-led opportunities within a 12-month period."},{"label":"Resubmission Policy","value":"Previously unsuccessful applications cannot be resubmitted within 12 months unless early resubmission is permitted."},{"label":"Renewal Rules","value":"Not explicitly defined; projects are expected to plan sustainability beyond the grant rather than rely on renewal."},{"label":"International Agreements","value":"Applications may be submitted through international agreements with Luxembourg (FNR), Brazil (FAPESP), or Norway (RCN)."}]

Quick facts

Status
Open
Deadline
Rolling
Funding amount
£500,000 to £5 million
Funding band
Mid (£500k-£5M)
Funding type
Grant
Payment type
Grant (typically 80% FEC in arrears)
Audience
Research Innovation
Industry
Sector agnostic
Last updated
9 Jun 2026
Published
26 Nov 2025